From: A review of reproducible and transparent research practices in urology publications from 2014 to2018
Characteristics | Variables | |
---|---|---|
Characteristics of included publications | ||
 | N (%) | |
Funding (N = 294) | University | 4 (1.36%) |
Hospital | 1 (0.34%) | |
Public | 23 (7.82%) | |
Private/Industry | 20 (6.80%) | |
Non-profit | 2 (0.68%) | |
Mixed | 28 (9.52%) | |
No statement listed | 185 (62.93%) | |
No funding received | 31 (10.54%) | |
Type of study (N = 294) | No empirical data | 115 (39.12%) |
Meta-analysis | 9 (3.06%) | |
Chart review | 10 (0.34%) | |
Clinical trial | 22 (7.48%) | |
Case study | 6 (2.04%) | |
Case series | 2 (0.68%) | |
Cohort | 94 (31.97%) | |
Case sontrol | 2 (0.68%) | |
Survey | 8 (2.72%) | |
Laboratory | 17 (5.78%) | |
Other | 9 (3.06%) | |
5-year impact factor (N = 274) | Median | 2.466 |
1st Quartile | 1.898 | |
3rd Quartile | 4.925 | |
Interquartile range | 1.898–4.925 |